Autologous genetically modified gamma-delta T cells

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Autologous genetically modified gamma-delta T cells
Treatment and conditionWhere it standsTrials
Autologous genetically modified gamma-delta T cells for glioblastomaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1